In a historic trading session that has sent shockwaves through global commodity markets, Comex silver futures settled nearly 4% higher today, February 25, 2026, closing at a staggering $90.24 per ounce. The breach of the $90 psychological resistance mark represents a watershed moment for the "devil's metal," which has
Media, broadcasting, and digital services company E.W. Scripps (NASDAQ:SSP) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 23.1% year on year to $560.3 million. Its GAAP loss of $0.51 per share was significantly below analysts’ consensus estimates.
In a resounding vote of confidence for the retail and cloud giant, Bank of America Corp (NYSE: BAC) has officially reiterated its "Buy" rating on Amazon.com Inc. (NASDAQ: AMZN), designating the company as a "top pick" for the 2026 fiscal year. The endorsement comes at a pivotal moment as
In a bold move that signals a potential bottom for one of the tech sector's most volatile titans, Oppenheimer has upgraded Oracle (NYSE: ORCL) to an "Outperform" rating, setting a price target of $185. The upgrade comes at a critical juncture on February 25, 2026, as the enterprise software giant
Nutanix shares are soaring in extended trading Wednesday after the company reports fiscal second-quarter results and announced a strategic partnership with AMD.
Multinational media and entertainment corporation Paramount (NASDAQ:PSKY) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.1% year on year to $8.15 billion. On the other hand, next quarter’s revenue guidance of $7.25 billion was less impressive, coming in 2.3% below analysts’ estimates. Its GAAP loss of $0.52 per share was significantly below analysts’ consensus estimates.
As the United States economy navigates a complex transition period in early 2026, new data from Automatic Data Processing (NASDAQ: ADP) suggests a resilient, albeit uneven, labor market. For the fourth consecutive week, the private sector has recorded consistent job gains, signaling a potential stabilization after the volatility seen throughout
The home improvement landscape is facing a prolonged winter of stagnation. On February 24, 2026, Home Depot (NYSE:HD) released its fourth-quarter and full-year fiscal 2025 results, delivering a sobering message to investors: the American housing market remains "frozen." Despite beating Wall Street's earnings expectations, the retail giant warned that
In a move that has sent shockwaves through the semiconductor industry and Silicon Valley, AMD (NASDAQ: AMD) shares surged 9% following the announcement of a landmark, multi-year strategic partnership with Meta Platforms (NASDAQ: META). The deal, characterized by analysts as one of the largest hardware procurement agreements in the history
Aviation and fleet aftermarket services provider VSE Corporation (NASDAQ:VSEC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $301.2 million. Its non-GAAP profit of $1.16 per share was 29.9% above analysts’ consensus estimates.
The global landscape of HIV prevention and treatment has reached a historic turning point following the clinical triumph and subsequent commercial launch of Gilead Sciences’ (Nasdaq: GILD) lenacapavir, now marketed as Yeztugo. As of February 25, 2026, the biopharmaceutical giant has successfully transitioned from a provider of daily oral regimens
The American consumer is proving more resilient than many on Wall Street dared to hope. In a surprise turn of events, the Conference Board reported on February 25, 2026, that its Consumer Confidence Index climbed to 91.2 in February, a significant jump from January’s revised reading of 89.
Insurance and technology company HCI Group (NYSE:HCI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 52.1% year on year to $246.2 million. Its GAAP profit of $7.25 per share was 58.5% above analysts’ consensus estimates.
In a definitive move to dominate the next frontier of immunology and oncology, Eli Lilly and Company (NYSE: LLY) announced on February 9, 2026, its acquisition of Orna Therapeutics for a total transaction value of up to $2.4 billion. The deal centers on Orna’s proprietary circular RNA (oRNA)
Beverage company Zevia (NYSE:ZVIA) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 4% year on year to $37.87 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $41 million at the midpoint, or 1.2% above analysts’ estimates. Its GAAP loss of $0.02 per share was in line with analysts’ consensus estimates.
SoundHound AI stock could triple over the next 12 months, but only if these critical growth milestones fall into place. Here's what investors need to watch next.
Burger restaurant chain Red Robin (NASDAQ:RRGB) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 5.7% year on year to $269 million. Its non-GAAP loss of $0.41 per share was 30.2% above analysts’ consensus estimates.
Personal care company The Honest Company (NASDAQ:HNST) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 11.8% year on year to $88.04 million. Its GAAP loss of $0.21 per share was significantly below analysts’ consensus estimates.
On February 6, 2026, the financial world witnessed a watershed moment as the Dow Jones Industrial Average (DJIA) eclipsed the 50,000-point mark for the first time in its 130-year history. This monumental achievement, closing at 50,115.67, represents more than just a psychological victory; it signals a fundamental
Water management company Northwest Pipe (NASDAQ:NWPX) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 5% year on year to $125.6 million. Its non-GAAP profit of $0.93 per share was 50% above analysts’ consensus estimates.
NEW YORK — In a milestone that once seemed years away, the S&P 500 (NYSEARCA: SPY) has officially breached the historic 7,000 level, marking a new frontier for American equity markets. This psychological and structural barrier was finally broken in late January 2026, culminating a relentless 14-month climb from
Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per share was 8.7% below analysts’ consensus estimates.
In a landmark decision that has sent shockwaves through the global trade ecosystem, the Supreme Court ruled 6-3 on February 20, 2026, to strike down the White House’s "Liberation Day" emergency tariff program. The Court found that the administration overstepped its constitutional authority by using the International Emergency Economic
The landscape of American monetary policy shifted dramatically on January 30, 2026, when President Donald Trump officially nominated Kevin Warsh to succeed Jerome Powell as the next Chair of the Federal Reserve. This nomination, occurring just months before Powell’s term concludes in May, signals a definitive pivot from the
Debt recovery company Encore Capital Group (NASDAQ:ECPG) announced better-than-expected revenue in Q4 CY2025, with sales up 78.3% year on year to $473.6 million. Its GAAP profit of $3.37 per share was 51.1% above analysts’ consensus estimates.
Financial services provider CBIZ (NYSE:CBZ) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 17.9% year on year to $542.7 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP loss of $0.70 per share was 6.2% below analysts’ consensus estimates.
In a move aimed at reshaping the American social contract, President Donald Trump used his February 2026 State of the Union address to unveil "America’s 401(k)," a government-backed retirement initiative designed to provide portable, high-efficiency savings accounts to millions of workers currently locked out of the private pension
American restaurant chain BJ’s Restaurants (NASDAQ:BJRI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 3.2% year on year to $355.4 million. Its non-GAAP profit of $0.66 per share was 5.7% above analysts’ consensus estimates.
SCOTTSDALE, AZ — Shares of Axon Enterprise (NASDAQ: AXON) surged more than 17% in heavy trading on Wednesday, February 25, 2026, reaching new record highs after the public safety technology giant reported fourth-quarter 2025 financial results that blew past Wall Street expectations. The company’s performance was bolstered by a staggering
Medical device company LeMaitre Vascular (NASDAQ:LMAT) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.7% year on year to $64.45 million. Guidance for next quarter’s revenue was better than expected at $66.6 million at the midpoint, 0.7% above analysts’ estimates. Its GAAP profit of $0.68 per share was 2.5% above analysts’ consensus estimates.
Vacation ownership company Marriott Vacations (NYSE:VAC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.32 billion. Its non-GAAP profit of $1.86 per share was 9% above analysts’ consensus estimates.
As the closing bell rang on February 25, 2026, all eyes in the financial world turned to the headquarters of Salesforce (NYSE: CRM). The cloud giant’s Fourth Quarter 2026 earnings report, released today, arrives at a moment of existential crisis for the software industry. Following a brutal start to
Solar tracking systems manufacturer Array (NASDAQ:ARRY) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 17.9% year on year to $226 million. The company expects the full year’s revenue to be around $1.45 billion, close to analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Energy recovery device manufacturer Energy Recovery (NASDAQ:ERII) missed Wall Street’s revenue expectations in Q4 CY2025, with sales flat year on year at $66.87 million. Its non-GAAP profit of $0.53 per share was 20.9% below analysts’ consensus estimates.
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $642.3 million. On the other hand, next quarter’s revenue guidance of $609 million was less impressive, coming in 3.8% below analysts’ estimates. Its GAAP loss of $0.14 per share was 24% above analysts’ consensus estimates.
